Delivery Order SPE2DB22D3501-SPE2DB25FTG34
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $26,175.31 firm-fixed-price contract is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical supplies and pharmaceuticals to various...
This is a $11,957.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for 4567243096 ACTIVASE 50 MG VIALS, a critical medical product, with a period of performance through February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, acting as a prime vehicle for providing a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 100 MG VIALS, a medical product, with a ceiling value of $34,803.82 and a completion date of October 13, 2023. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,743.76 and is for the delivery of ACTIVASE 50 MG VIALS, a medical product. It is a firm fixed price contract with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,379.52, is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of June 23, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,479.90, is for the supply of ACTIVASE 50 MG VIALS medical products. The contract has an ultimate completion date of June 6, 2025 and is not set aside for a particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $8,578.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of ACTIVASE 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for $7,778.45. The contract is for the delivery of ACTIVASE 50 MG VIALS, a medical product, with a completion date of June 4, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $83,574.45 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a specialized medication, to support military healthcare programs. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTIVASE 100 MG VIALS. The $5,713.85 firm fixed price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical products and medical supplies to support military treatment...